Advancing pharmaceutical excellence through research & partnership
Champions Pharmaceuticals supports Nigeria's healthcare system through regulated distribution, evidence-based research, and long-standing partnerships with government, military-medical and international health institutions.
A Nigerian pharmaceutical institution built on heritage and evidence
Registered on 4 June 1993, Champions Pharmaceuticals came out of a family pharmaceutical heritage that spans generations, and set out to serve Nigeria's healthcare needs with regulated, documented, quality-assured medicine.
Our work today runs across three connected areas: regulated distribution, structured research and development, and public-health partnership. All of it is held to NAFDAC and Federal Ministry of Health standards.
Four connected focus areas
Structured R&D methodology applied across therapeutic and scientific domains, each grounded in reproducible evidence.
Pharmaceutical Distribution
Regulated distribution networks ensuring safe, effective, NAFDAC-registered medicines reach healthcare institutions nationwide.
Regulatory Compliance
Strict adherence to NAFDAC standards and international pharmaceutical regulation for verifiable quality assurance.
Public-Health Partnership
Collaboration with government agencies, the military-medical corps and international bodies supporting national health goals.
Research & Development
Structured investigation in oncology, regenerative medicine, haematology and global-health policy.
Evidence-based research initiatives
Advancing pharmaceutical science through systematic literature review, translational research and international collaboration.
Advanced Stem Cell Research & Treatment Pathways
Mesenchymal and haematopoietic stem-cell applications in oncology and regenerative medicine.
Read study
Pharma-Grade Scorpion Venom, Oncology Compound
Bioactive peptides and Chlorotoxin (Tumor Paint) in cancer-selective therapeutics.
Read study
Sickle Cell Disease: From Management to Functional Cure
Gene editing, stem-cell transplantation and disease-modifying pharmacotherapy.
Read studyLatest from Champions
Announcements, research milestones and partnership updates from across the group.
Six active research programmes now published
Evidence syntheses across oncology, regenerative medicine, haematology and global-health policy.
Read more
Advancing needleless & injectable delivery
Proposed initiatives with the Federal Ministry of Health and NPHCDA to improve access to safer therapies.
Read more
Continued alignment with national health standards
Ongoing engagement with NAFDAC and the Federal Ministry of Health across the country.
Read moreAdvancing needleless drug delivery in Nigeria
A strategic initiative with the Federal Ministry of Health, NPHCDA and international partners to pioneer needleless delivery systems, support national vaccination campaigns and improve access to safer therapies nationwide.
Strategic partnerships & affiliations
Building bridges across healthcare sectors through long-standing partnerships with government agencies, the military-medical corps, international organisations and regulatory bodies.
Pharm. Society of Nigeria
Partner with Champions Pharmaceuticals
We welcome strategic dialogue with healthcare stakeholders, government agencies and international partners advancing pharmaceutical excellence and healthcare access across Nigeria.